Stock Events

Stock Events

Seer 

$1.6800
12
-$0.26-13.4%Friday 20:00
-$0.02-1.19%Friday 23:58After hours

Statistics

Day High
1.69
Day Low
1.68
52W High
2.38
52W Low
1.55
Volume
4,787
Avg. Volume
-
Mkt Cap
93.02M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

Nov 10Expected
Q1 2025
Q2 2025
Q3 2025
Q4 2025
Q1 2026
Q2 2026
Next
-0.37
-0.33
-0.3
-0.26
Expected EPS
-0.26
Actual EPS
N/A

Financials

-443.96%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
16.58MRevenue
-73.6MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow SEER. It's not an investment recommendation.
Apple
5
AAPL
Amazon
4
AMZN
Microsoft
3
MSFT
Tesla
3
TSLA

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Thermo Fisher Scientific
TMO
Mkt Cap242.11B
Thermo Fisher Scientific offers a wide range of analytical instruments and reagents, directly competing with Seer's proteomics and analytical tools.
Illumina
ILMN
Mkt Cap41.23B
Illumina provides genomic sequencing and array-based technologies, competing in the broader life sciences market alongside Seer's proteomics focus.
Waters
WAT
Mkt Cap41.78B
Waters Corporation specializes in liquid chromatography and mass spectrometry, technologies that are foundational to proteomics research, making it a direct competitor.
Agilent Technologies
A
Mkt Cap47.3B
Agilent Technologies offers a broad portfolio of instruments, software, services, and consumables for laboratory workflow, directly competing with Seer in the life sciences sector.
Bio-Rad Laboratories
BIO
Mkt Cap9.87B
Bio-Rad Laboratories provides a range of products for the life science research and clinical diagnostics markets, overlapping with Seer's target market.
Bruker
BRKR
Mkt Cap9.64B
Bruker Corporation designs and manufactures scientific instruments, including for proteomics, directly competing with Seer's technology offerings.
Pacific Biosciences of California
PACB
Mkt Cap789.51M
Pacific Biosciences offers genomic analysis systems, competing in the broader genomics and life sciences space where Seer operates.
Guardant Health
GH
Mkt Cap23.86B
Guardant Health focuses on liquid biopsies and cancer diagnostics, competing in the life sciences market by offering complementary technologies to Seer's.
Qiagen NV
QGEN
Mkt Cap9.24B
Qiagen provides sample and assay technologies for molecular diagnostics, applied testing, academic and pharmaceutical research, competing in the life sciences tools market.
Danaher
DHR
Mkt Cap150.48B
Danaher Corporation owns a portfolio of life sciences companies, offering products and services that compete across several of Seer's key areas.

About

Seer Inc is a life sciences company, develops and commercializes products to decode the biology of the proteome. The company offers Proteograph Product Suite, an integrated solution that includes proprietary engineered nanoparticles, consumables, automation instrumentation, and data analysis software to perform proteomic analysis to provide a solution that can be incorporated by nearly any lab for research use only. It markets and sells its products for research use only, which cover academic institutions, life sciences, and research laboratories, as well as biopharmaceutical and biotechnology companies for non-diagnostic and non-clinical purposes. The company operates in China, Australia, Eastern Europe, Israel, Japan and South Africa.
Show More
CEO
Omid C. Farokhzad
Employees
124
Country
United States
ISIN
US81578P1066

Listings

BOATS
BOATS
SEER.BOATS
XNAS
US
SEER

0 Comments

Share your thoughts

FAQs

What is Seer stock price today?▼
The current price of SEER is $1.68 USD — it has decreased by -13.4% in the past 24 hours. Watch Seer stock price performance more closely on the chart.
What is Seer stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange Seer stocks are traded under the ticker SEER.
Is Seer stock price growing?▼
SEER stock has fallen by -12.95% compared to the previous week, the month change is a -25.33% fall, over the last year Seer has showed a -23.98% decrease.
What is Seer market cap?▼
Today Seer has the market capitalization of 93.02M
When is the next Seer earnings date?▼
Seer is going to release the next earnings report on November 10, 2026.
What were Seer earnings last quarter?▼
SEER earnings for the last quarter are -0.31 USD per share, whereas the estimation was -0.27 USD resulting in a -14.81% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Seer revenue for the last year?▼
Seer revenue for the last year amounts to 16.58M USD.
What is Seer net income for the last year?▼
SEER net income for the last year is -73.6M USD.
How many employees does Seer have?▼
As of November 2, 2026, the company has 124 employees.
In which sector is Seer located?▼
Seer operates in the Health & Wellness sector.
When did Seer complete a stock split?▼
Seer has not had any recent stock splits.
Where is Seer headquartered?▼
Seer is headquartered in REDWOOD CITY, United States.